Petkova-Gueorguieva Elina, Gueorguiev Stanislav, Lebanova Hristina, Madzharov Vasil, Mihaylova Anna
Department of Health Policy and Management, Faculty of Public Health, Medical Univercity of Sofia, 15 Akademik Ivan Evstratiev Geshov Blvd, 1431 Sofia, Bulgaria.
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Medical University of Plovdiv, 15A Vasil Aprilov Street, 4002 Plovdiv, Bulgaria.
Int J Anal Chem. 2022 Jul 9;2022:3950190. doi: 10.1155/2022/3950190. eCollection 2022.
The aim of the study was to analyze the presence of undeclared sildenafil, tadalafil, and vardenafil in food supplements (FSs) for erectile dysfunction. The presence of sildenafil, tadalafil, and vardenafil was determined using the generated ultraviolet (UV)-spectra and mass-spectrometry (MS)-spectra as well as chromatograms produced by the photodiode array (PDA)-detector and ion trap MS-detector. The results were processed by Xcalibur ver. 2.0.7. Fourteen of the 20 analyzed FSs contained undeclared ingredients. Sildenafil was present in 12 of them. Many violations and discrepancies between the label information and the real composition of the FS were identified. 70% of the samples contained undeclared ingredients of an erectile dysfunction medicinal product. The quantities varied within broad limits from 2 mg per tablet to 116.55 mg per tablet. Sildenafil was present in amounts exceeding 16.55 mg that is the maximum recommended dose, thus creating risk of overdose. Besides that, food supplements adulterated with sildenafil analogues are a health risk for consumer's health as there is no evidence of modified sildenafil toxicity. All analyzed FSs were claimed to be 100% natural, not provoking side effects. No information for any FS contained indications of age limits or risk for interaction with other FSs or medical products.
本研究的目的是分析用于治疗勃起功能障碍的食品补充剂(FSs)中未申报的西地那非、他达拉非和伐地那非的存在情况。使用生成的紫外(UV)光谱和质谱(MS)光谱以及光电二极管阵列(PDA)检测器和离子阱MS检测器产生的色谱图来测定西地那非、他达拉非和伐地那非的存在情况。结果由Xcalibur ver. 2.0.7软件处理。在分析的20种FSs中,有14种含有未申报成分。其中12种含有西地那非。发现了许多标签信息与FS实际成分之间的违规和差异。70%的样品含有治疗勃起功能障碍药品的未申报成分。含量在很宽的范围内变化,从每片2毫克到每片116.55毫克不等。西地那非的含量超过了16.55毫克,即最大推荐剂量,从而产生了过量用药的风险。除此之外,掺有西地那非类似物的食品补充剂对消费者健康构成健康风险,因为没有证据表明改性西地那非的毒性有所改变。所有分析的FSs都声称是100%天然的,不会引起副作用。任何FSs的信息中都没有包含年龄限制或与其他FSs或医疗产品相互作用风险的说明。